Coronary artery necroses and calcification in chronic coronary heart disease


如何引用文章

全文:

详细

Aim. To study some particularly inadequately studied mechanisms for the development of coronary artery calcification (CAC), which are unassociated with calcified atheromatous masses of atherosclerotic plaques.
Subjects and methods. Endarterectomized coronary artery (CA) segments obtained during aortocoronary bypass surgery were pathomorphologically studied in 150 patients aged 49-72 years with coronary heart disease (CHD). CAC was found in 92% of cases. Two types of CAC were identified: one of them was associated with calcified atheromatous masses of atherosclerotic plaques; the other was related to necroses in the fibrous plaque parts. The atheromatous masses exhibited calcareous deposits as fine-grained masses of small extent. In chronic CHD, morphological signs of instability of atherosclerotic plaques were observed in 23.3% of cases, these being associated with lamellar CAC in two thirds.
Conclusion. Calcification in the necrotic area of fibrous parts of stenotic plaques is typical of chronic CHD and is frequently attended by the development of large-focal calcareous deposits generally as laminas (lamellar calcification). Impaired transmural perfusion of plasma is noted to be involved in the development of necroses in stenotic CA atherosclerotic plaques.

作者简介

Valentin Zhdanov

Email: vs.zhdanov@cardio.ru

Nina Cherpachenko

Iraida Drobkova

Svetlana Veselova

Tat'yana Shlychkova

V Zhdanov

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

N Cherpachenko

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

I Drobkova

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

S Veselova

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

T Shlychkova

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

A. L. Myasnikov Cardiology Research Institute, Russian Cardiology Research-and-Production Complex, Russian Agency for Medical Technologies

参考

  1. Вихерт А. М., Седов К. Р., Соколова Р. И. Кальциноз артерий. М.: Медицина; 1970.
  2. Вихерт А. М., Жданов В. С. Атеросклероз при различных заболеваниях. М.: Медицина; 1976.
  3. Жданов В. С., Вихерт А. М., Стернби Н. Г. Эволюция и патология атеросклероза человека. М.: Триада-Х; 2002.
  4. Аничков Н. Н. Сосуды. В кн.: Абрикосов А. И. Частная патанатомия. М.; 1947; т. 2: 262-483.
  5. Stary H. C. The development of calcium deposits in atherosclerotic lesions and their persistence after lipid regression. Am. J. Cardiol. 2001; 88(2A): 16E-19E.
  6. Терновой С. К., Синицын В. Е., Гагарина Н. В. Неинвазивная диагностика атеросклероза и кальциноза коронарных артерий. М.: Атмосфера; 2003.
  7. McClelland R. L., Bild D. E., Burke G. L. et al. Alcohol and coronary artery calcium prevalence, incidence, and progression: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Am. J. Clin. Nutr. 2008; 88(6): 1953-1961.
  8. Лапин Ю. А. О морфогенезе вторичных обызвествлений венечных артерий сердца. Арх. пат. 1959; 21: 3-9.
  9. Шевченко О. П., Мишнев О. Д. Ишемическая болезнь сердца. М.: Реафарм; 2005.
  10. Jellinnek H., Detre Z., Veress B. Transmural plasma flow in atherogenesis. Budapest; 1983.
  11. Карпов Ю. А., Сорокин Е. В. Стабильная ишемическая болезнь сердца. М.; 2003.
  12. Лилли Л. (ред.). Патофизиология заболеваний сердечно-сосудистой системы. 2-е изд. М.; 2007.
  13. Mayer B., Lieb W., Radke P. W. et al. Association between arterial pressure and coronary artery calcification. J. Hypertens. 2007; 27(8): 1731-1738.
  14. Achenbach S., Ropers D., Pohle K. et al. Influence of lipid-lowering therapy on progression of coronary artery calcification: a prospective evaluation. Circulation 2002; 106(9): 1077-1082.
  15. Budoff V. J., Lane K. L., Bakhshenshi H. et al. Rates of progression of coronary calcium by electron beam tomography. Am. J. Cardiol. 2000; 86(1): 8-11.
  16. Nicholls S. J., Tuzcu E. M., Wolski K. et al. Coronary artery calcification and changes in atheroma burden in response to established medical therapies. J. Am. Coll. Cardiol. 2007; 49(2): 271-273.
  17. Terry J. G., Carr J. J., Kouva E. O. et al. Effect of simvastatin (80 mg) on coronary and abdominal aortic arterial calcium (from the coronary artery calcification treatment with zocor [CATZ] study). Am. J. Cardiol. 2007; 99(12): 1714-1717.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2010

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house


##common.cookie##